Nicolas Levoin

5PUBLICATIONS
12CO-AUTHORS
Proteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 29, 2025
Research towards selective inhibition of the CLK3 kinase.

Vinay Kumar Singh, Frédéric Justaud, Dabbugoddu Brahmaiah

|Oct 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathways.

Eden Lebrault, Christelle Oblet, Keerthi Kurma

|Oct 23, 2022
MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways.

Shoji F Kenji, Keerthi Kurma, Brigitte Collet

|Oct 14, 2022
Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases.

Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna

|Nov 16, 2018
Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammation.

Amanda Poissonnier, Jean-Philippe Guégan, Ha Thanh Nguyen

Pageof 1

Frequent Collaborators

3 joint publications

Patrick Legembre

2 joint publications

Stéphane Bach

1 joint publications

Kalle Gehring

1 joint publications

Pierre Vacher